$ACOR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACORDA THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACORDA THERAPEUTICS INC. Get notifications about new insider transactions in ACORDA THERAPEUTICS INC for free.
Page: < prev 1 ... 12 13 14 15 16 17 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.04 | 1,400 | 22,456 | 55,177 | 56.6 K to 55.2 K (-2.47 %) |
| Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.05 | 1,600 | 25,680 | 56,577 | 58.2 K to 56.6 K (-2.75 %) |
| Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.06 | 800 | 12,848 | 58,177 | 59 K to 58.2 K (-1.36 %) |
| Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.07 | 1,500 | 24,105 | 58,977 | 60.5 K to 59 K (-2.48 %) |
| Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.08 | 900 | 14,472 | 60,477 | 61.4 K to 60.5 K (-1.47 %) |
| Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.09 | 653 | 10,507 | 61,377 | 62 K to 61.4 K (-1.05 %) |
| Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.10 | 700 | 11,270 | 62,030 | 62.7 K to 62 K (-1.12 %) |
| Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.11 | 600 | 9,666 | 62,730 | 63.3 K to 62.7 K (-0.95 %) |
| Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.12 | 100 | 1,612 | 63,330 | 63.4 K to 63.3 K (-0.16 %) |
| Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.13 | 500 | 8,065 | 63,430 | 63.9 K to 63.4 K (-0.78 %) |
| Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.14 | 200 | 3,228 | 63,930 | 64.1 K to 63.9 K (-0.31 %) |
| Nov 08 2006 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 16.22 | 100 | 1,622 | 64,130 | 64.2 K to 64.1 K (-0.16 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.73 | 850 | 14,221 | 346,093 | 346.9 K to 346.1 K (-0.24 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.74 | 970 | 16,238 | 346,943 | 347.9 K to 346.9 K (-0.28 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.75 | 1,230 | 20,603 | 347,913 | 349.1 K to 347.9 K (-0.35 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.76 | 100 | 1,676 | 349,143 | 349.2 K to 349.1 K (-0.03 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.79 | 500 | 8,395 | 349,243 | 349.7 K to 349.2 K (-0.14 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.80 | 1,400 | 23,520 | 349,743 | 351.1 K to 349.7 K (-0.40 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.83 | 250 | 4,208 | 351,143 | 351.4 K to 351.1 K (-0.07 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.87 | 200 | 3,374 | 351,393 | 351.6 K to 351.4 K (-0.06 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.95 | 500 | 8,475 | 351,593 | 352.1 K to 351.6 K (-0.14 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.00 | 5,724 | 97,308 | 352,093 | 357.8 K to 352.1 K (-1.60 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.01 | 1,596 | 27,148 | 357,817 | 359.4 K to 357.8 K (-0.44 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.02 | 700 | 11,914 | 359,413 | 360.1 K to 359.4 K (-0.19 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.03 | 200 | 3,406 | 360,113 | 360.3 K to 360.1 K (-0.06 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.05 | 1,038 | 17,698 | 360,313 | 361.4 K to 360.3 K (-0.29 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.07 | 1,200 | 20,484 | 361,351 | 362.6 K to 361.4 K (-0.33 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.10 | 1,815 | 31,037 | 362,551 | 364.4 K to 362.6 K (-0.50 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.11 | 3,192 | 54,615 | 364,366 | 367.6 K to 364.4 K (-0.87 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.12 | 1,135 | 19,431 | 367,558 | 368.7 K to 367.6 K (-0.31 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.13 | 1,200 | 20,556 | 368,693 | 369.9 K to 368.7 K (-0.32 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.14 | 400 | 6,856 | 369,893 | 370.3 K to 369.9 K (-0.11 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.15 | 2,450 | 42,018 | 370,293 | 372.7 K to 370.3 K (-0.66 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.16 | 4,400 | 75,504 | 372,743 | 377.1 K to 372.7 K (-1.17 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.18 | 1,200 | 20,616 | 377,143 | 378.3 K to 377.1 K (-0.32 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.19 | 900 | 15,471 | 378,343 | 379.2 K to 378.3 K (-0.24 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.20 | 1,449 | 24,923 | 379,243 | 380.7 K to 379.2 K (-0.38 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.21 | 1,151 | 19,809 | 380,692 | 381.8 K to 380.7 K (-0.30 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.22 | 1,000 | 17,220 | 381,843 | 382.8 K to 381.8 K (-0.26 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.24 | 218 | 3,758 | 382,843 | 383.1 K to 382.8 K (-0.06 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.25 | 700 | 12,075 | 383,061 | 383.8 K to 383.1 K (-0.18 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.30 | 1,200 | 20,760 | 383,761 | 385 K to 383.8 K (-0.31 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.31 | 300 | 5,193 | 384,961 | 385.3 K to 385 K (-0.08 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.32 | 82 | 1,420 | 385,261 | 385.3 K to 385.3 K (-0.02 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.35 | 3,850 | 66,798 | 385,343 | 389.2 K to 385.3 K (-0.99 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.36 | 300 | 5,208 | 389,193 | 389.5 K to 389.2 K (-0.08 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.37 | 900 | 15,633 | 389,493 | 390.4 K to 389.5 K (-0.23 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.38 | 414 | 7,195 | 390,393 | 390.8 K to 390.4 K (-0.11 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.39 | 1,000 | 17,390 | 390,807 | 391.8 K to 390.8 K (-0.26 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.41 | 800 | 13,928 | 391,807 | 392.6 K to 391.8 K (-0.20 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.42 | 500 | 8,710 | 392,607 | 393.1 K to 392.6 K (-0.13 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.45 | 2,186 | 38,146 | 393,107 | 395.3 K to 393.1 K (-0.55 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.49 | 400 | 6,996 | 395,293 | 395.7 K to 395.3 K (-0.10 %) |
| Nov 03 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 17.52 | 400 | 7,008 | 395,693 | 396.1 K to 395.7 K (-0.10 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Option Exercise | M | 2.60 | 144,810 | 376,506 | 0 | |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.63 | 500 | 8,315 | 59,274 | 59.8 K to 59.3 K (-0.84 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.62 | 500 | 8,310 | 59,774 | 60.3 K to 59.8 K (-0.83 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.61 | 900 | 14,949 | 60,274 | 61.2 K to 60.3 K (-1.47 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.60 | 12,400 | 205,840 | 61,174 | 73.6 K to 61.2 K (-16.85 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.58 | 600 | 9,948 | 73,574 | 74.2 K to 73.6 K (-0.81 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.57 | 700 | 11,599 | 74,174 | 74.9 K to 74.2 K (-0.93 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.56 | 200 | 3,312 | 74,874 | 75.1 K to 74.9 K (-0.27 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.55 | 13,000 | 215,150 | 75,074 | 88.1 K to 75.1 K (-14.76 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.40 | 1,281 | 21,008 | 88,074 | 89.4 K to 88.1 K (-1.43 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.38 | 100 | 1,638 | 89,355 | 89.5 K to 89.4 K (-0.11 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.37 | 10,000 | 163,700 | 89,455 | 99.5 K to 89.5 K (-10.05 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.36 | 4,600 | 75,256 | 99,455 | 104.1 K to 99.5 K (-4.42 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.35 | 13,861 | 226,627 | 104,055 | 117.9 K to 104.1 K (-11.75 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.30 | 10,000 | 163,000 | 117,916 | 127.9 K to 117.9 K (-7.82 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.20 | 14,680 | 237,816 | 127,916 | 142.6 K to 127.9 K (-10.29 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.17 | 1,800 | 29,106 | 142,596 | 144.4 K to 142.6 K (-1.25 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.16 | 1,664 | 26,890 | 144,396 | 146.1 K to 144.4 K (-1.14 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.08 | 1,300 | 20,904 | 146,060 | 147.4 K to 146.1 K (-0.88 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.07 | 2,100 | 33,747 | 147,360 | 149.5 K to 147.4 K (-1.41 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.06 | 100 | 1,606 | 149,460 | 149.6 K to 149.5 K (-0.07 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.05 | 4,213 | 67,619 | 149,560 | 153.8 K to 149.6 K (-2.74 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.03 | 2,700 | 43,281 | 153,773 | 156.5 K to 153.8 K (-1.73 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.02 | 300 | 4,806 | 156,473 | 156.8 K to 156.5 K (-0.19 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.01 | 5,987 | 95,852 | 156,773 | 162.8 K to 156.8 K (-3.68 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 15.95 | 3,253 | 51,885 | 162,760 | 166 K to 162.8 K (-1.96 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 15.92 | 1,600 | 25,472 | 166,013 | 167.6 K to 166 K (-0.95 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 15.91 | 600 | 9,546 | 167,613 | 168.2 K to 167.6 K (-0.36 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 15.90 | 3,000 | 47,700 | 168,213 | 171.2 K to 168.2 K (-1.75 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 15.88 | 400 | 6,352 | 171,213 | 171.6 K to 171.2 K (-0.23 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 15.87 | 2,882 | 45,737 | 171,613 | 174.5 K to 171.6 K (-1.65 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.37 | 700 | 11,459 | 418,093 | 418.8 K to 418.1 K (-0.17 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.38 | 2,000 | 32,760 | 418,793 | 420.8 K to 418.8 K (-0.48 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.39 | 1,400 | 22,946 | 420,793 | 422.2 K to 420.8 K (-0.33 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.40 | 5,446 | 89,314 | 422,193 | 427.6 K to 422.2 K (-1.27 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.41 | 2,354 | 38,629 | 427,639 | 430 K to 427.6 K (-0.55 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.42 | 100 | 1,642 | 429,993 | 430.1 K to 430 K (-0.02 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.43 | 1,800 | 29,574 | 430,093 | 431.9 K to 430.1 K (-0.42 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.44 | 1,800 | 29,592 | 431,893 | 433.7 K to 431.9 K (-0.42 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.45 | 500 | 8,225 | 433,693 | 434.2 K to 433.7 K (-0.12 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.46 | 700 | 11,522 | 434,193 | 434.9 K to 434.2 K (-0.16 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.47 | 1,300 | 21,411 | 434,893 | 436.2 K to 434.9 K (-0.30 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.48 | 1,100 | 18,128 | 436,193 | 437.3 K to 436.2 K (-0.25 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.49 | 200 | 3,298 | 437,293 | 437.5 K to 437.3 K (-0.05 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.51 | 100 | 1,651 | 437,493 | 437.6 K to 437.5 K (-0.02 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.56 | 700 | 11,592 | 437,593 | 438.3 K to 437.6 K (-0.16 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.57 | 227 | 3,761 | 438,293 | 438.5 K to 438.3 K (-0.05 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.60 | 1,215 | 20,169 | 438,520 | 439.7 K to 438.5 K (-0.28 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.61 | 458 | 7,607 | 439,735 | 440.2 K to 439.7 K (-0.10 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.68 | 900 | 15,012 | 440,193 | 441.1 K to 440.2 K (-0.20 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.69 | 400 | 6,676 | 441,093 | 441.5 K to 441.1 K (-0.09 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.71 | 200 | 3,342 | 441,493 | 441.7 K to 441.5 K (-0.05 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.73 | 400 | 6,692 | 441,693 | 442.1 K to 441.7 K (-0.09 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.74 | 800 | 13,392 | 442,093 | 442.9 K to 442.1 K (-0.18 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.75 | 700 | 11,725 | 442,893 | 443.6 K to 442.9 K (-0.16 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.76 | 400 | 6,704 | 443,593 | 444 K to 443.6 K (-0.09 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.78 | 400 | 6,712 | 443,993 | 444.4 K to 444 K (-0.09 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.80 | 300 | 5,040 | 444,393 | 444.7 K to 444.4 K (-0.07 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.81 | 300 | 5,043 | 444,693 | 445 K to 444.7 K (-0.07 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.87 | 800 | 13,496 | 444,993 | 445.8 K to 445 K (-0.18 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.92 | 300 | 5,076 | 445,793 | 446.1 K to 445.8 K (-0.07 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 15.88 | 300 | 4,764 | 396,093 | 396.4 K to 396.1 K (-0.08 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 15.92 | 400 | 6,368 | 396,393 | 396.8 K to 396.4 K (-0.10 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.07 | 700 | 11,249 | 396,793 | 397.5 K to 396.8 K (-0.18 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.08 | 100 | 1,608 | 397,493 | 397.6 K to 397.5 K (-0.03 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.09 | 400 | 6,436 | 397,593 | 398 K to 397.6 K (-0.10 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.10 | 300 | 4,830 | 397,993 | 398.3 K to 398 K (-0.08 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.13 | 600 | 9,678 | 398,293 | 398.9 K to 398.3 K (-0.15 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.14 | 300 | 4,842 | 398,893 | 399.2 K to 398.9 K (-0.08 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.16 | 300 | 4,848 | 399,193 | 399.5 K to 399.2 K (-0.08 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.18 | 1,600 | 25,888 | 399,493 | 401.1 K to 399.5 K (-0.40 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.19 | 400 | 6,476 | 401,093 | 401.5 K to 401.1 K (-0.10 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.20 | 2,665 | 43,173 | 401,493 | 404.2 K to 401.5 K (-0.66 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.22 | 400 | 6,488 | 404,158 | 404.6 K to 404.2 K (-0.10 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.23 | 700 | 11,361 | 404,558 | 405.3 K to 404.6 K (-0.17 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.25 | 719 | 11,684 | 405,258 | 406 K to 405.3 K (-0.18 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.26 | 281 | 4,569 | 405,977 | 406.3 K to 406 K (-0.07 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.27 | 1,900 | 30,913 | 406,258 | 408.2 K to 406.3 K (-0.47 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.28 | 100 | 1,628 | 408,158 | 408.3 K to 408.2 K (-0.02 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.29 | 1,318 | 21,470 | 408,258 | 409.6 K to 408.3 K (-0.32 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.30 | 1,100 | 17,930 | 409,576 | 410.7 K to 409.6 K (-0.27 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.31 | 1,900 | 30,989 | 410,676 | 412.6 K to 410.7 K (-0.46 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.33 | 600 | 9,798 | 412,576 | 413.2 K to 412.6 K (-0.15 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.34 | 1,917 | 31,324 | 413,176 | 415.1 K to 413.2 K (-0.46 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.35 | 1,200 | 19,620 | 415,093 | 416.3 K to 415.1 K (-0.29 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President & CEO | Sell | S | 16.36 | 1,800 | 29,448 | 416,293 | 418.1 K to 416.3 K (-0.43 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.89 | 1,080 | 18,241 | 15,714 | 16.8 K to 15.7 K (-6.43 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.85 | 3,800 | 64,030 | 16,794 | 20.6 K to 16.8 K (-18.45 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.82 | 1,467 | 24,675 | 20,594 | 22.1 K to 20.6 K (-6.65 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.81 | 1,400 | 23,534 | 22,061 | 23.5 K to 22.1 K (-5.97 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.80 | 7,000 | 117,600 | 23,461 | 30.5 K to 23.5 K (-22.98 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.78 | 1,000 | 16,780 | 30,461 | 31.5 K to 30.5 K (-3.18 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.75 | 1,883 | 31,540 | 31,461 | 33.3 K to 31.5 K (-5.65 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.71 | 4,091 | 68,361 | 33,344 | 37.4 K to 33.3 K (-10.93 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.70 | 3,909 | 65,280 | 37,435 | 41.3 K to 37.4 K (-9.45 %) |
| Oct 18 2006 | ACOR | ACORDA THERAPEUTIC ... | PINNEY MARK R E | Director | Sell | S | 16.67 | 1,000 | 16,670 | 41,344 | 42.3 K to 41.3 K (-2.36 %) |